This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Proteome Profiler Human XL Oncology Array
catalog :
ARY026
quantity :
1 Kit
price :
890 USD
citations: 29
Reference
Stickler S, Lang C, Rieche M, Eggerstorfer M, Hohenegger M, Hochmair M, et al. Characterization of a pleomorphic rhabdomyosarcoma cell line. Sci Rep. 2025;15:2893 pubmed publisher
Haase A, Alefeld E, Yalinci F, Meenen D, Busch M, D xfc nker N. Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells. Cancers (Basel). 2024;16: pubmed publisher
Namusamba M, Wu Y, Yang J, Zhang Q, Wang C, Wang T, et al. BAP31 Promotes Angiogenesis via Galectin-3 Upregulation in Neuroblastoma. Int J Mol Sci. 2024;25: pubmed publisher
Hochmann J, Mill xe1 n M, Hern xe1 ndez P, Lafon Hughes L, Aiuto N, Silva A, et al. Contributions of viral oncogenes of HPV-18 and hypoxia to oxidative stress and genetic damage in human keratinocytes. Sci Rep. 2023;13:17734 pubmed publisher
Herrspiegel C, Plastino F, Lardner E, Seregard S, Williams P, Andr xe9 H, et al. A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival. BMC Cancer. 2023;23:277 pubmed publisher
Suh A, Suzuki D, Gychka S, Brelidze T, Suzuki Y. gp120 Envelope Glycoproteins of HIV-1 Group M Subtype A and Subtype B Differentially Affect Gene Expression in Human Vascular Endothelial Cells. Int J Mol Sci. 2023;24: pubmed publisher
Malyla V, Paudel K, Rubis G, Hansbro N, Hansbro P, Dua K. Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling. Int J Mol Sci. 2023;24: pubmed publisher
Jagadeeshan S, Prasad M, Badarni M, Ben Lulu T, Liju V, Mathukkada S, et al. Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer. Cancer Res. 2023;83:1031-1047 pubmed publisher
Suh A, Suzuki D, Gychka S, Brelidze T, Suzuki Y. gp120 envelope glycoproteins of HIV-1 Group M Subtype A and Subtype B differentially affect gene expression in human vascular endothelial cells. bioRxiv. 2023;: pubmed publisher
Pulford C, Uppalapati C, Montgomery M, Averitte R, Hull E, Leyva K. A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues. Int J Mol Sci. 2022;23: pubmed publisher
Vanneste D, Staal J, Haegman M, Driege Y, Carels M, Van Nuffel E, et al. CARD14 Signalling Ensures Cell Survival and Cancer Associated Gene Expression in Prostate Cancer Cells. Biomedicines. 2022;10: pubmed publisher
Anchan A, Finlay G, Angel C, Hucklesby J, Graham S. Melanoma Mediated Disruption of Brain Endothelial Barrier Integrity Is Not Prevented by the Inhibition of Matrix Metalloproteinases and Proteases. Biosensors (Basel). 2022;12: pubmed publisher
Katsuda Y, Sato S, Inoue M, Tsugawa H, Kamura T, Kida T, et al. Small molecule-based detection of non-canonical RNA G-quadruplex structures that modulate protein translation. Nucleic Acids Res. 2022;50:8143-8153 pubmed publisher
Alnuqaydan A, Almutary A, Azam M, Manandhar B, Yin G, Yen L, et al. Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine-Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro. Pharmaceutics. 2022;14: pubmed publisher
Zerfaoui M, Toraih E, Ruiz E, Errami Y, Attia A, Krzysztof M, et al. Nuclear Localization of BRAFV600E Is Associated with HMOX-1 Upregulation and Aggressive Behavior of Melanoma Cells. Cancers (Basel). 2022;14: pubmed publisher
Ni Z, Lu J, Huang W, Khan H, Wu X, Huang D, et al. Transcriptomic identification of HBx-associated hub genes in hepatocellular carcinoma. Peerj. 2021;9:e12697 pubmed publisher
Stoup N, Liberelle M, Schulz C, Cavdarli S, Vasseur R, Magnez R, et al. The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis. Cancers (Basel). 2021;13: pubmed publisher
Fatima I, Barman S, Uppada J, Chauhan S, Rauth S, Rachagani S, et al. MASTL regulates EGFR signaling to impact pancreatic cancer progression. Oncogene. 2021;40:5691-5704 pubmed publisher
Grassi E, Pantazopoulou V, Pietras A. Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma. Oncogene. 2020;39:4028-4044 pubmed publisher
Mosley M, Baguña Torres J, Allen D, Cornelissen B. Immuno-imaging of ICAM-1 in tumours by SPECT. Nucl Med Biol. 2020;84-85:73-79 pubmed publisher
Smagurauskaite G, Mahale J, Brown K, Thomas A, Howells L. New Paradigms to Assess Consequences of Long-Term, Low-Dose Curcumin Exposure in Lung Cancer Cells. Molecules. 2020;25: pubmed publisher
Argentiero A, De Summa S, Di Fonte R, Iacobazzi R, Porcelli L, Da Vià M, et al. Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study. Cancers (Basel). 2019;11: pubmed publisher
Elie B, Hubbard K, Pechenyy Y, Layek B, Prabha S, Contel M. Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma. Cancer Med. 2019;8:4304-4314 pubmed publisher
Uppada S, Gowrikumar S, Ahmad R, Kumar B, Szeglin B, Chen X, et al. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling. Mol Cancer. 2018;17:111 pubmed publisher
Scheers N, Pereira D, Faria N, Powell J. Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells. Oncotarget. 2018;9:17066-17077 pubmed publisher
Ku B, Choi M, Sun J, Lee S, Ahn J, Park K, et al. Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model. PLoS ONE. 2018;13:e0194730 pubmed publisher
Chen X, Wang Z, Ma H, Zhang S, Yang H, Wang H, et al. Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma. Oncotarget. 2017;8:93580-93592 pubmed publisher
Liu Y, Wang J, Ni T, Wang L, Wang Y, Sun X. CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells. Oncotarget. 2016;7:25328-39 pubmed publisher
Hamilton G, Hochmair M, Rath B, Klameth L, Zeillinger R. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype. Cell Adh Migr. 2016;10:360-7 pubmed publisher
product information
master code :
ARY026
SKU :
ARY026
product name :
Proteome Profiler Human XL Oncology Array
unit size :
1 Kit
description :
The Proteome Profiler Human XL Oncology Array from R&D Systems Contains 4 membranes-each spotted in duplicate with 84 different cancer-related antibodies.
target :
Oncology Array Kit
category :
Proteome Profiler Antibody Arrays
species :
Human
extended description :
Contains 4 membranes-each spotted in duplicate with 84 different cancer-related antibodies
USD :
890 USD
product details :
Contains 4 membranes-each spotted in duplicate with 84 different cancer-related antibodies
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.